Literature DB >> 21159128

Letter to the editor. Crohn's disease.

Avad Ahmed Mughal, Mabs Chowdhury, Barney Hawthorne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21159128      PMCID： PMC7950970          DOI： 10.1111/j.1742-481X.2010.00757.x

Source DB:  PubMed          Journal:  Int Wound J        ISSN： 1742-4801            Impact factor:   3.315


× No keyword cloud information.
  7 in total

Review 1.  Immunogenicity of Anti-TNF-alpha agents in autoimmune diseases.

Authors:  Nádia Emi Aikawa; Jozélio Freire de Carvalho; Clovis Artur Almeida Silva; Eloísa Bonfá
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 2.  Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis.

Authors:  R Balfour Sartor
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2006-07

3.  Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study.

Authors:  M E Weinblatt; E C Keystone; D E Furst; A F Kavanaugh; E K Chartash; O G Segurado
Journal:  Ann Rheum Dis       Date:  2005-11-24       Impact factor: 19.103

Review 4.  Cutaneous Crohn's disease in children.

Authors:  T Ploysangam; J E Heubi; D Eisen; W F Balistreri; A W Lucky
Journal:  J Am Acad Dermatol       Date:  1997-05       Impact factor: 11.527

5.  Cutaneous manifestations of Crohn's disease.

Authors:  W Burgdorf
Journal:  J Am Acad Dermatol       Date:  1981-12       Impact factor: 11.527

6.  Response of cutaneous Crohn's disease to infliximab and methotrexate.

Authors:  A Konrad; F Seibold
Journal:  Dig Liver Dis       Date:  2003-05       Impact factor: 4.088

7.  Metastatic cutaneous Crohn's disease.

Authors:  J L Sutphen; P H Cooper; S E Mackel; D L Nelson
Journal:  Gastroenterology       Date:  1984-05       Impact factor: 22.682
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.